Formulation and Evaluation of Gastroretentive Floating Pellets of Nizatidine
Main Article Content
Abstract
Aim: The aim of the study was to develop gastroretentive floating pellets containing H2 –receptor antagonist,
nizatidine which is primarily absorbed from stomach and has low oral bioavailability. Materials and Methods: The
gastroretentive floating pellets of nizatidine were formulated using hydroxypropyl methylcellulose (HPMC)
K100M and ethyl cellulose (EC) as sustained-release polymer, and NaHCO3 as a gas-forming agent. Pellets were
prepared by extrusion–spheronization technique using microcrystalline cellulose as spheronizing agent. A 32 full
factorial design was applied to investigate the effect of the two independent variables, that is, concentration of
HPMC K100M (X1) and concentration of EC (X2) on the dependent variables, in vitro drug release at 1 h (Y1),
in vitro drug release at 4 h (Y2), in vitro drug release at 8 h (Y3), and floating lag time (Y4). Results: The optimized
formulation (F0) exhibits a floating lag time of around 70 ± 2 s and in vitro drug release of 99.89% at 12 h. The
in vitro release of F1-F9 batches were found in between 99.87% and 84.43% at 12 h. Floating lag time of F1-F9
batches was found to be 36 ± 1 s–84 ± 3 s. Conclusion: HPMC K100 M and EC had a significant effect on
floating lag time and in vitro drug release. Scanning electron microscope photomicrograph of pellets revealed
that the surface was rough and the pellets were spherical shaped in nature. The in-vitro release kinetics revealed
Korsmeyer-Peppas model is followed and drug release is by anomalous diffusion.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.